Anastomosis Devices Market Size, Share, Growth, and Industry Analysis, By Type (Disposable,Reusable), By Application (Cardiovascular Surgery,Gastrointestinal Surgery,Others), Regional Insights and Forecast to 2035

Anastomosis Devices Market Overview

The global Anastomosis Devices Market size is projected to grow from USD 2113.37 million in 2026 to USD 2235.95 million in 2027, reaching USD 3502.41 million by 2035, expanding at a CAGR of 5.8% during the forecast period.

The Anastomosis Devices Market comprises medical tools and implants used to join two vessels or hollow structures (vascular, gastrointestinal, etc.). In 2024, over 4,300 anastomoses were constructed in a study of connector technologies across 14 designs in 4,311 patients. Technologies include staplers, suture-based connectors, and sealant devices. Typical connector devices support internal diameters of 2.0–2.5 mm vessels and blood-exposed non-intimal surfaces (BENIS) up to 15 mm². The Anastomosis Devices Industry Report must address both disposable and reusable systems, and performance metrics like patency, leak rate, and ease of use.

In the United States, over 900,000 cardiac surgeries are performed annually, many involving vascular bypass or grafting and requiring anastomosis devices. The U.S. leads adoption of powered staplers and connector systems in ~40–50 million major procedures per year globally. American regulatory norms and hospital procurement favor single-use disposable connectors in ~86% of new purchases. U.S. hospitals maintain 3–5 brands in inventory, and surgeons undergo 20–40 device trainings annually. The Anastomosis Devices Market Analysis for the U.S. must align with cardiac procedure volume, reimbursement practices, and hospital device standardization.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 58 of 100 surgical centers report adoption of minimally invasive anastomosis tools reduced operative time by 15–25%.
• Major Market Restraint: 37 of 100 hospitals cite high device acquisition and maintenance costs as obstacles in low-resource settings.
• Emerging Trends: 52 of 100 new device launches between 2023–2025 include robotic-assisted or automated connector systems.
• Regional Leadership: 34 of 100 market share (by volume) is held by North America in the anastomosis devices sector.
• Competitive Landscape: 45 of 100 procurement deals are with the top two or three device suppliers in many national markets.
• Market Segmentation: 60 of 100 devices sold are disposables; 40 of 100 are reusable in settings with sterilization infrastructure.
• Recent Development: 40 of 100 new device clearances in 2024 included bioabsorbable materials and anti-thrombogenic coatings.

Anastomosis Devices Market Latest Trends

In the Anastomosis Devices Market Trends, innovations focus on automation, robotics, bioabsorbable connectors, and leak-free sealing. In recent years, ~50–60% of new device launches integrate robotic or semi-automated actuation to reduce suturing time. Some systems claim to reduce anastomosis time by 20–30% compared to hand-sewn. Bioabsorbable connector materials (e.g. magnesium alloys, polymer composites) have entered trials; these devices degrade over 6–24 months, leaving no permanent foreign body. Leak-resistant sealing designs using hydrogel or polymer seals reduce anastomotic leak rates from 2–5% to 1–2% in clinical tests. Hybrid connectors combining staples + adhesives account for ~10–15% of new offerings. Robotic surgical platforms now support ~15–25% of gastrointestinal anastomoses in high-volume centers. Integration of real-time sensor feedback (pressure, flow) in connector systems is present in ~5–10% of advanced prototypes. The Anastomosis Devices Market Forecast will need to consider robotics penetration, adoption curves, and performance reliability.

Anastomosis Devices Market Dynamics

DRIVER

"Rising surgical procedure volumes and shift toward minimally invasive surgery"

The main driver is increased numbers of cardiovascular, gastrointestinal, oncologic, and bariatric surgeries that require anastomoses. Globally, over 310 million major surgeries occur annually, and cardiovascular surgery accounts for ~50% of device usage. Minimally invasive and laparoscopic surgeries now account for 60–70% of gastrointestinal and colorectal cases in developed markets, driving demand for fast, reliable anastomosis devices. Robotic surgical systems support ~200,000+ procedures yearly, with increasing use of connector devices in robotic workflows. 

RESTRAINT

"High device cost, regulatory regimes, and clinical adoption inertia"

A principal restraint is high purchase cost: advanced anastomosis devices (robotic connectors, bioabsorbable systems) may cost 2–4× traditional sutures. In resource-constrained settings, uptake is limited; surveys show 30–40% of hospitals decline adoption due to budget oversight. Regulatory approval is arduous: device trials often require 300–500 patient implants to demonstrate safety, leak, and patency.

OPPORTUNITY

"Entry into emerging markets and remote hospital networks"

Emerging markets present strong opportunity: many developing countries still rely solely on manual suturing, with connector penetration < 10%. Introducing lower-cost connectors could capture 20–30% of open surgery markets. Tele-training, bundled service models, and leasing of connector systems can reduce upfront adoption costs. Remote and rural hospitals performing general surgeries can benefit from easier, standardized anastomosis tools to reduce operative risk. 

CHALLENGE

"Clinical validation, safety assurance, and long-term patency"

A key challenge is demonstrating long-term clinical outcomes. Devices must show patency and leak rates on par with hand-sewn sutures over 1–5 year follow-up. In a pooled study of 4,328 anastomoses, connector devices (674) had noninferior patency compared with hand-sewn in 4,311 patients. Some connector systems failed in small vessel (< 2.0 mm) applications. 

Anastomosis Devices Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

The Anastomosis Devices Market segments by Type (Disposable, Reusable) and Application (Cardiovascular Surgery, Gastrointestinal Surgery, Others). Disposable systems dominate with ~86–90% of sales volume, while reusable connectors (sterilizable) account for ~10–14% depending on region. Application share: cardiovascular surgery consumes ~40–55%, gastrointestinal surgery ~30–45%, and other surgeries (urology, transplant) ~5–10%. This segmentation drives product strategy, pricing, regional penetration, and R&D prioritization in the Anastomosis Devices Market Report.

BY TYPE 

Disposable: Disposable anastomosis devices dominate usage, accounting for ~86–90% of devices because they offer sterility, convenience, and lower cross-contamination risk. Hospitals prefer disposables to avoid sterilization logistics and validation overhead. Typical usage: a single procedure consumes 1–3 disposable connectors per anastomosis. Overhead hospitals deploy inventory kits of 10–50 units per OR per procedure day. Many disposable systems incorporate bioabsorbable materials, coatings, or adhesives, increasing complexity.

The Disposable Anastomosis Devices segment is projected to hold a substantial share with a market size of USD 1321.24 million in 2025, growing to USD 2228.74 million by 2034 at a CAGR of 6.1%, driven by infection control and single-use preferences.

Top 5 Major Dominant Countries in the Disposable Segment

• United States: The U.S. Disposable Anastomosis Devices market is valued at USD 410.62 million in 2025, expected to reach USD 705.18 million by 2034, expanding at a CAGR of 6.2%, supported by advanced surgical infrastructure.
• Germany: Germany’s market size of USD 142.57 million in 2025 is anticipated to reach USD 234.40 million by 2034, with a CAGR of 5.6%, driven by adoption of minimally invasive technologies.
• China: China’s Disposable Anastomosis Devices market will grow from USD 121.33 million in 2025 to USD 218.61 million by 2034, recording a CAGR of 6.9% due to rising surgical volume.
• Japan: Japan’s market is projected to increase from USD 110.48 million in 2025 to USD 185.36 million by 2034, expanding at a CAGR of 5.8%, supported by its aging population.
• India: India’s Disposable Anastomosis Devices market, worth USD 82.14 million in 2025, is forecasted to hit USD 147.19 million by 2034, growing at a CAGR of 6.7%, fueled by healthcare modernization.

Reusable: Reusable anastomosis devices represent ~10–14% of usage in settings with robust sterilization infrastructure, such as tertiary hospitals in developed markets. Reusable connectors are made from durable metals or ceramics designed for 50–100+ sterilization cycles. Hospitals amortize their capital cost over many procedures, lowering cost per use.

The Reusable Anastomosis Devices segment accounts for a significant share, with a market size of USD 676.27 million in 2025, projected to reach USD 1081.67 million by 2034 at a CAGR of 5.1%, driven by cost efficiency and sustainability trends.

Top 5 Major Dominant Countries in the Reusable Segment

• United States: The U.S. Reusable Anastomosis Devices market stands at USD 215.33 million in 2025, reaching USD 339.82 million by 2034, with a CAGR of 5.2%, supported by high-end hospital adoption.
• United Kingdom: The U.K. market, valued at USD 68.71 million in 2025, is set to reach USD 109.45 million by 2034, expanding at a CAGR of 5.4%, aided by NHS surgical improvements.
• China: China’s Reusable Anastomosis Devices market will grow from USD 72.96 million in 2025 to USD 121.09 million by 2034, with a CAGR of 5.9%, driven by local manufacturing growth.
• Japan: Japan’s market, valued at USD 61.24 million in 2025, is projected to reach USD 97.50 million by 2034, at a CAGR of 5.2%, boosted by repeat hospital purchases.
• France: France’s market will rise from USD 53.13 million in 2025 to USD 85.81 million by 2034, recording a CAGR of 5.4%, supported by increasing surgical training programs.

BY APPLICATION

Cardiovascular Surgery: Cardiovascular surgery is the largest segment, capturing ~40–55% of device usage. Coronary artery bypass grafting (CABG), valve replacement, and vascular bypass require precise arterial or venous anastomoses. In Europe alone, ~181,000 bypass graft anastomoses were performed across EU25 in a given recent year.

The Cardiovascular Surgery segment holds a major market share with USD 855.36 million in 2025, growing to USD 1462.78 million by 2034 at a CAGR of 6.1%, driven by the rising incidence of cardiac disorders.

Top 5 Major Dominant Countries in the Cardiovascular Surgery Application

• United States: The U.S. market stands at USD 290.24 million in 2025, reaching USD 513.98 million by 2034, with a CAGR of 6.3%, fueled by high cardiac surgery rates.
• Germany: Germany’s cardiovascular segment will grow from USD 93.14 million in 2025 to USD 156.72 million by 2034, at a CAGR of 5.9%, driven by advanced clinical setups.
• China: China’s market is expected to increase from USD 88.63 million in 2025 to USD 157.23 million by 2034, expanding at a CAGR of 6.7%, supported by rising heart disease prevalence.
• Japan: Japan’s cardiovascular market, worth USD 74.18 million in 2025, is projected to reach USD 121.61 million by 2034, with a CAGR of 5.8%.
• France: France’s segment, valued at USD 63.12 million in 2025, will reach USD 105.89 million by 2034, registering a CAGR of 6.0%.

Gastrointestinal Surgery: Gastrointestinal surgery, including colorectal, bariatric, and general resection surgeries, accounts for ~30–45% of connector device use. In GI procedures, circular stapler plus connector sequences are common for bowel anastomoses, often requiring 1–2 connectors per anastomosis. Hospitals schedule 500–2,000 GI anastomosis procedures annually.

The Gastrointestinal Surgery segment is estimated at USD 723.64 million in 2025, projected to reach USD 1142.53 million by 2034 at a CAGR of 5.3%, owing to increasing bariatric and colorectal surgeries.

Top 5 Major Dominant Countries in the Gastrointestinal Surgery Application

• United States: U.S. market size of USD 236.47 million in 2025 is forecasted to hit USD 368.91 million by 2034, expanding at a CAGR of 5.2%, driven by rising obesity surgeries.
• China: China’s market will grow from USD 117.69 million in 2025 to USD 197.42 million by 2034, showing a CAGR of 6.0%, aided by improved surgical accessibility.
• Japan: Japan’s market is projected at USD 92.11 million in 2025, reaching USD 145.86 million by 2034, with a CAGR of 5.2%, due to advancements in laparoscopic procedures.
• Germany: Germany’s gastrointestinal segment will grow from USD 89.36 million in 2025 to USD 138.25 million by 2034, recording a CAGR of 4.9%.
• India: India’s market, valued at USD 74.01 million in 2025, is expected to hit USD 122.09 million by 2034, increasing at a CAGR of 5.8%.

Others: “Others” includes urologic, transplant, pulmonary, and vascular reconstructive surgeries, accounting for ~5–10% of connector usage. In transplant procedures, vascular anastomosis and organ vessel connections require high precision; many connectors are used in kidney, liver, and pancreas transplants. In vascular surgery, peripheral bypass grafts use connectors in ~10–15% of cases in advanced centers.

The Others segment, including urological and neurological surgeries, accounts for USD 418.51 million in 2025, projected to reach USD 705.10 million by 2034 at a CAGR of 6.0%, due to broader surgical applications.

Top 5 Major Dominant Countries in the Others Application

• United States: The market is valued at USD 137.89 million in 2025, projected to reach USD 235.64 million by 2034, expanding at a CAGR of 6.1%, driven by neurovascular device integration.
• China: China’s segment will increase from USD 79.16 million in 2025 to USD 138.10 million by 2034, at a CAGR of 6.2%, supported by surgical expansion.
• Germany: Germany’s market, valued at USD 65.73 million in 2025, will reach USD 108.52 million by 2034, with a CAGR of 5.7%.
• Japan: Japan’s market will expand from USD 57.43 million in 2025 to USD 97.12 million by 2034, registering a CAGR of 6.1%.
• France: France’s segment is projected to grow from USD 50.30 million in 2025 to USD 84.72 million by 2034, at a CAGR of 6.0%.

Anastomosis Devices Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Geographically, the Anastomosis Devices Market is dominated by North America (~35–40%), Europe (~25%), Asia-Pacific (~20–25%), and Middle East & Africa (~5–10%) of device volume. North America leads adoption, Europe emphasizes regulatory innovation, Asia-Pacific is the fastest growing, and MEA is nascent but expanding in high-end surgical hubs. Regional differences in healthcare infrastructure, reimbursement, surgical volumes, and regulatory frameworks drive market strategies and device penetration in the Anastomosis Devices Market Report.

NORTH AMERICA

In North America, particularly the U.S., the Anastomosis Devices Market commands ~35–40% of global volume. The U.S. performed ~900,000+ cardiac surgeries annually part of total major surgeries, driving heavy use of cardiovascular connectors. Disposable connectors dominate U.S. procurement (~86% share), with hospitals deploying multiple brands and maintaining surgical stock of 20–50 units per OR. Extensive adoption of robotic systems (~200,000+ procedures) supports integration of connector automation.

The North America Anastomosis Devices market holds a leading position with a market size of USD 716.92 million in 2025, expected to reach USD 1218.37 million by 2034 at a CAGR of 5.9%, driven by advanced surgical infrastructure.

North America - Major Dominant Countries in the Anastomosis Devices Market

• United States: Market valued at USD 570.12 million in 2025, reaching USD 972.45 million by 2034, growing at a CAGR of 6.0%.
• Canada: Canada’s market will grow from USD 88.91 million in 2025 to USD 148.10 million by 2034, at a CAGR of 5.7%.
• Mexico: Market size of USD 57.89 million in 2025 is projected to hit USD 97.82 million by 2034, with a CAGR of 5.8%.
• Cuba: The market will rise from USD 8.96 million in 2025 to USD 14.87 million by 2034, recording a CAGR of 5.6%.
• Costa Rica: Costa Rica’s market is forecasted to grow from USD 5.04 million in 2025 to USD 8.83 million by 2034, at a CAGR of 6.0%.

EUROPE

Europe contributes ~25% of connector device volume, with high usage in Germany, UK, France, Italy, and the Nordics. The European vascular and GI surgery volume is robust: Germany performs ~51,000 bypass operations annually. European hospitals increasingly adopt bioabsorbable connectors and robotic systems.

The Europe Anastomosis Devices market is valued at USD 555.46 million in 2025, expected to reach USD 891.23 million by 2034, growing at a CAGR of 5.4%, driven by healthcare modernization and surgical technology adoption.

Europe - Major Dominant Countries in the Anastomosis Devices Market

• Germany: Market valued at USD 166.25 million in 2025, reaching USD 263.85 million by 2034, with a CAGR of 5.4%.
• France: France’s market grows from USD 104.93 million in 2025 to USD 172.15 million by 2034, at a CAGR of 5.6%.
• United Kingdom: U.K. market will increase from USD 89.78 million in 2025 to USD 147.83 million by 2034, recording a CAGR of 5.5%.
• Italy: Italy’s market is projected to grow from USD 79.34 million in 2025 to USD 125.72 million by 2034, expanding at a CAGR of 5.3%.
• Spain: Spain’s market rises from USD 65.16 million in 2025 to USD 106.45 million by 2034, with a CAGR of 5.6%.

ASIA-PACIFIC

Asia-Pacific commands ~20–25% of the connector device market and is the fastest-growing zone. Countries like China, Japan, South Korea, India, and Southeast Asia are seeing rapid adoption of advanced surgical techniques. China and India perform tens to hundreds of thousands of cardiac and GI surgeries annually. Many hospitals in Asia are upgrading to international device systems, with connector usage in advanced centers reaching 20–30% of anastomoses. Domestic OEMs are producing lower-cost connectors for emerging market penetration.

The Asia Anastomosis Devices market stands at USD 512.81 million in 2025, anticipated to reach USD 922.73 million by 2034, expanding at a CAGR of 6.7%, led by rising healthcare infrastructure and surgical volumes.

Asia - Major Dominant Countries in the Anastomosis Devices Market

• China: Market valued at USD 193.63 million in 2025, growing to USD 352.85 million by 2034, with a CAGR of 6.8%.
• Japan: Japan’s market expands from USD 160.44 million in 2025 to USD 278.99 million by 2034, recording a CAGR of 6.1%.
• India: India’s market grows from USD 111.82 million in 2025 to USD 204.74 million by 2034, at a CAGR of 6.9%.
• South Korea: Market size of USD 72.14 million in 2025 will rise to USD 131.25 million by 2034, with a CAGR of 6.5%.
• Australia: Australia’s market will increase from USD 51.88 million in 2025 to USD 95.07 million by 2034, showing a CAGR of 6.8%.

MIDDLE EAST & AFRICA

Middle East & Africa represent ~5–10% of global connector device usage. Leading centers in UAE, Saudi Arabia, South Africa, and Israel adopt advanced connectors particularly in cardiac and transplant centers. Many MEA hospitals maintain surgical device inventories sufficient for 50–100 procedures as import cycles are long. In some cases, connectors are bundled with high-end donor surgery packages to attract medical tourism patients across the region. Regulatory environments vary: some Gulf states require device registration with 3–5 year clinical data, while others accept CE or U.S. clearances.

The Middle East and Africa Anastomosis Devices market is projected to grow from USD 212.32 million in 2025 to USD 378.08 million by 2034, expanding at a CAGR of 6.0%, supported by hospital infrastructure upgrades.

Middle East and Africa - Major Dominant Countries in the Anastomosis Devices Market

• United Arab Emirates: Market valued at USD 61.26 million in 2025, reaching USD 106.28 million by 2034, growing at a CAGR of 6.1%.
• Saudi Arabia: Market will rise from USD 55.89 million in 2025 to USD 96.12 million by 2034, at a CAGR of 6.0%.
• South Africa: Market grows from USD 41.82 million in 2025 to USD 72.89 million by 2034, with a CAGR of 5.9%.
• Egypt: Egypt’s market expands from USD 28.90 million in 2025 to USD 51.67 million by 2034, at a CAGR of 6.3%.
• Israel: Market increases from USD 24.45 million in 2025 to USD 42.12 million by 2034, with a CAGR of 5.8%.

List of Top Anastomosis Devices Companies

• Medtronic
• LivaNova PLC.
• MAQUET Holding B.V. & KG.
• Dextera Surgical
• Vitalitec Internaional
• Synovis Micro Companies Alliance
• Ethicon US, LLC.

Medtronic: estimated market share ~15–20% in connector and stapler devices, with broad global distribution.

Ethicon US, LLC: commands ~12–15% share in suturing and stapler connectors across gastrointestinal and cardiovascular segments.

Investment Analysis and Opportunities

Between 2023 and 2025, investment in the anastomosis devices field surged with >25 new R&D and commercialization projects. Typical investments in new connector design, robotic integration, and polymer coatings range between USD 5–20 million per development program. Hospitals and surgical centers are entering device consortia or group purchasing contracts to negotiate lower prices on bulk orders. 

New Product Development

From 2023 to 2025, developers released >15 next-generation anastomosis devices emphasizing robotics, sensor integration, and bioabsorbable materials. Several connectors now include pressure/flow sensors for real-time patency feedback during implantation. New robotic-assisted connectors support automated alignment and fastening, reducing surgeon manual steps by 20–30%. Bioabsorbable connectors that degrade over 12–24 months emerged in prototypes to reduce long-term foreign body footprint.

Five Recent Developments

• 2023: Lydus Medical obtained FDA 510(k) clearance for its Vesseal microvascular connector, entering U.S. vascular surgery markets.
• 2023: A major medical device company launched a robotic-assisted anastomosis stapler deployed in 20+ U.S. hospitals for GI and bariatric procedures.
• 2024: An OEM introduced a bioabsorbable anastomosis connector system that degrades over 18 months; early trials in 100+ patients showed leak rates below 1.5%.
• 2024: A European consortium initiated a multi-center registry tracking 5,000 GI anastomoses using new connector systems to assess durability and complication rates.
• 2025: A company launched a sensor-integrated connector providing intraoperative flow data, used in over 500 CABG cases in initial deployment, with surgeons citing decision support benefits.

Report Coverage of Anastomosis Devices Market

This Anastomosis Devices Market Research Report offers detailed coverage across device types, surgical applications, competitive landscape, regional dynamics, and future outlook. It segments devices into Disposable and Reusable types, and surgical uses into Cardiovascular, Gastrointestinal, and Others. The report analyzes clinical demand: U.S. cardiac surgeries exceed 900,000 annually, and 181,000 bypass-anastomosis procedures take place yearly in EU member states. 

Anastomosis Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 2113.37 Million in 2026
Market Size Value By	USD 3502.41 Million by 2035
Growth Rate	CAGR of 5.8% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Disposable Reusable By Application : Cardiovascular Surgery Gastrointestinal Surgery Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample